Evidence map›Paper›PMID 27029910›Full record

ArticleEpidemiology and infection2016

Testing the accuracy ratio of the Spatio-Temporal Epidemiological Modeler (STEM) through Ebola haemorrhagic fever outbreaks.

F Baldassi, F D'Amico, M Carestia, O Cenciarelli, S Mancinelli, F Gilardi, A Malizia, D DI Giovanni, P M Soave, C Bellecci and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Study on the Global Stability for a Generalized SEIR Epidemic Model.Computational intelligence and neuroscience · 2022
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

F BaldassiInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
F D'AmicoInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
M CarestiaInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
O CenciarelliInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.ORCID 0000-0002-8679-4918
S MancinelliInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
F GilardiInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
A MaliziaInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
D DI GiovanniInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
P M SoaveInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
C BellecciInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.ORCID 0000-0002-5129-119X
P GaudioInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
L PalombiInternational Master Courses in Protection Against CBRNe events,Department of Industrial Engineering and School of Medicine and Surgery,University of Rome Tor Vergata,Italy.
University of Rome Tor Vergata · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mathematical modelling is an important tool for understanding the dynamics of the spread of infectious diseases, which could be the result of a natural outbreak or of the intentional release of pathogenic biological agents. Decision makers and policymakers responsible for strategies to contain disease, prevent epidemics and fight possible bioterrorism attacks, need accurate computational tools, based on mathematical modelling, for preventing or even managing these complex situations. In this article, we tested the validity, and demonstrate the reliability, of an open-source software, the Spatio-Temporal Epidemiological Modeler (STEM), designed to help scientists and public health officials to evaluate and create models of emerging infectious diseases, analysing three real cases of Ebola haemorrhagic fever (EHF) outbreaks: Uganda (2000), Gabon (2001) and Guinea (2014). We discuss the cases analysed through the simulation results obtained with STEM in order to demonstrate the capability of this software in helping decision makers plan interventions in case of biological emergencies.

Indexed as

Disease OutbreaksCommunicable Diseases, EmergingDemocratic Republic of the CongoEbolavirusGabonGuineaHemorrhagic Fever, EbolaHumansPopulation SurveillanceReproducibility of ResultsSoftwareUgandaEbola virusinfectious diseasemathematical modellingviral haemorrhagic fevervirology

Identifiers

PMID27029910
PMCPMC9150585
OpenAlexW2287020632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.